NEELS GUIDO J — SEC Form 4 filings
SEC reporting owner CIK 1222362. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-06-10 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 50,000 shares, $52,600 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 4,073 shares, $43,215 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 4,073 shares @ $10.61 ($43,215) in Axogen, Inc., filed 2025-06-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ELUTIA INC. (ELUT) | Director | 6 | 3 legs · 50,000 sh · $52,600 | — | 6 |
| Axogen, Inc. (AXGN) | Director | 3 | — | 1 leg · 4,073 sh · $43,215 | 4 |
| Bioventus Inc. (BVS) | Director | 4 | — | — | 9 |
| TELA Bio, Inc. (TELA) | Director | 1 | — | — | 4 |
Form 4 filings — NEELS GUIDO J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | ELUTIA INC. (ELUT) | Grant/award (A): 106,393 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | TELA Bio, Inc. (TELA) | Grant/award (A): 11,925 @ $0 · Grant/award (A): 11,675 @ $0 · Grant/award (A): 17,550 (derivative) @ $0 · Grant/award (A): 17,335 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 32,282 @ $0 · Option exercise (M): 32,282 (derivative) @ $0 · Grant/award (A): 25,146 (derivative) @ $0 | EDGAR |
| 2026-04-14 | 4 | ELUTIA INC. (ELUT) | Option exercise (M): 6,250 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | ELUTIA INC. (ELUT) | Purchase (P): 20,000 @ $1.04 | EDGAR |
| 2026-01-29 | 4 | ELUTIA INC. (ELUT) | Purchase (P): 15,000 @ $1.06 · Purchase (P): 15,000 @ $1.06 | EDGAR |
| 2025-12-02 | 4 | ELUTIA INC. (ELUT) | Option exercise (M): 6,250 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2025-10-14 | 4 | ELUTIA INC. (ELUT) | Grant/award (A): 171,916 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Axogen, Inc. (AXGN) | Sale (S): 4,073 @ $10.61 | EDGAR |
| 2025-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 26,493 @ $0 · Option exercise (M): 26,493 (derivative) @ $0 · Grant/award (A): 32,282 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | Axogen, Inc. (AXGN) | Option exercise (M): 11,904 @ $0 · Option exercise (M): 11,904 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Bioventus Inc. (BVS) | Grant/award (A): 26,493 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 30,400 @ $0 · Option exercise (M): 30,400 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Axogen, Inc. (AXGN) | Grant/award (A): 10,653 · Grant/award (A): 18,248 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1222362 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →